Published in Psychiatr Genet on April 01, 2011
Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depress Anxiety (2012) 0.83
Development × environment interactions control tph2 mRNA expression. Neuroscience (2013) 0.79
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression. J Psychopharmacol (2013) 0.78
Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders. J Neurosci Res (2017) 0.75
Association of tryptophan hydroxylase-2 polymorphisms with oppositional defiant disorder in a Chinese Han population. Behav Brain Funct (2016) 0.75
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord (2007) 1.78
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52
Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr (2009) 1.41
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.40
A review of psychiatric genetics research in the Brazilian population. Rev Bras Psiquiatr (2009) 1.40
Cognitive impairment in a Brazilian sample of patients with bipolar disorder. Rev Bras Psiquiatr (2008) 1.39
Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res (2010) 1.37
Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev (2007) 1.36
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett (2007) 1.35
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.28
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci (2006) 1.11
Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry (2013) 1.11
Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease. Pediatr Nephrol (2010) 1.08
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci (2006) 1.08
Functional impairment and disability across mood states in bipolar disorder. Value Health (2010) 1.06
Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord (2009) 1.06
Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord (2007) 1.01
The serum S100B concentration is age dependent. Clin Chem (2002) 1.01
Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother (2011) 0.99
Increased serum levels of CCL11/eotaxin in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.99
Development and use of a biological rhythm interview. J Affect Disord (2009) 0.99
TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.99
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett (2008) 0.99
Functional impact of biological rhythm disturbance in bipolar disorder. J Psychiatr Res (2009) 0.98
Differential effects of emotional arousal in short- and long-term memory in healthy adults. Neurobiol Learn Mem (2003) 0.97
Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.97
Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry (2014) 0.96
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care (2010) 0.96
The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol (2008) 0.94
Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord (2006) 0.94
Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2008) 0.94
Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord (2009) 0.92
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr (2010) 0.91
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.91
Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation (2008) 0.91
Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. J Psychiatr Res (2007) 0.91
Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun (2009) 0.91
BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology (2011) 0.90
Brazilian Portuguese version of the Iowa Gambling Task: transcultural adaptation and discriminant validity. Rev Bras Psiquiatr (2008) 0.90
Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test. Pharmacol Biochem Behav (2006) 0.90
Circadian preference in bipolar disorder. Sleep Breath (2009) 0.90
From neuroprogression to neuroprotection: implications for clinical care. Med J Aust (2010) 0.90
Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res (2006) 0.90
Clinical impact of late diagnose of bipolar disorder. J Affect Disord (2005) 0.89
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res Bull (2009) 0.89
Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry (2011) 0.89
Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol (2006) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis (2012) 0.88
Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res (2013) 0.88
Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res (2010) 0.88
Validity of a short functioning test (FAST) in Brazilian outpatients with bipolar disorder. Value Health (2009) 0.88
Decision-making impairment is related to serotonin transporter promoter polymorphism in a sample of patients with obsessive-compulsive disorder. Behav Brain Res (2008) 0.88
Cognitive performance and quality of life in bipolar disorder. Can J Psychiatry (2008) 0.88
Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program. Bipolar Disord (2011) 0.88
Increased levels of adipokines in bipolar disorder. J Psychiatr Res (2011) 0.88
Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett (2006) 0.87
Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem Res (2010) 0.87
Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder. J Affect Disord (2008) 0.87
Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal. Psychopharmacology (Berl) (2014) 0.87
Insulin dysfunction and allostatic load in bipolar disorder. Expert Rev Neurother (2011) 0.87
BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells. J Mol Neurosci (2009) 0.86
Social phobia in Brazilian university students: prevalence, under-recognition and academic impairment in women. J Affect Disord (2011) 0.86
Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res (2006) 0.86
Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett (2009) 0.86
Neuropsychological assessment of impulsive behavior in abstinent alcohol-dependent subjects. Rev Bras Psiquiatr (2009) 0.86
Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep (2012) 0.86
Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behav Pharmacol (2007) 0.86
Acute and chronic electroconvulsive shock in rats: effects on peripheral markers of neuronal injury and glial activity. Life Sci (2006) 0.85
C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry (2015) 0.85
Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett (2009) 0.85
Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version. Parkinsonism Relat Disord (2009) 0.85
Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.85
Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol (2011) 0.85
Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res (2012) 0.85
Mismatch between self-reported quality of life and functional assessment in acute mania: a matter of unawareness of illness? J Affect Disord (2007) 0.85
Early life stress interacts with the diet deficiency of omega-3 fatty acids during the life course increasing the metabolic vulnerability in adult rats. PLoS One (2013) 0.85
Anxiety comorbidity and quality of life in bipolar disorder patients. Can J Psychiatry (2007) 0.85
Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J Affect Disord (2012) 0.85
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis. Rev Bras Psiquiatr (2005) 0.85
Intense exercise induces mitochondrial dysfunction in mice brain. Neurochem Res (2007) 0.84
Effects of beta-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res Bull (2009) 0.84
Seasonal distribution and demographical characteristics of carpal tunnel syndrome in 1039 patients. Arq Neuropsiquiatr (2004) 0.84
Decreased expression of DARPP-32 in oral premalignant and malignant lesions. Anticancer Res (2007) 0.83
Downhill training upregulates mice hippocampal and striatal brain-derived neurotrophic factor levels. J Neural Transm (Vienna) (2008) 0.83
Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behav Brain Res (2013) 0.83
The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder. J Affect Disord (2008) 0.83